Overview

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
0
Participant gender:
All
Summary
Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bayer
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Criteria
Inclusion Criteria:

- Patient is >/= 2 months of age through 16 years of age

- A parent/caregiver must sign an informed consent

- Patient must provide assent, as appropriate based on local institutional review board
guidelines

Exclusion Criteria:

- Patients presenting with the following conditions:

- exacerbations of cystic fibrosis (CF)

- meningitis

- Brain abscess

- bacterial endocarditis,

- Bone and joint infections

- having any of the following conditions but lacking a personal history may be admitted
to the trial:

- Arthritis

- Juvenile rheumatoid arthritis (JRA)

- Rheumatoid arthritis (RA)

- Systemic lupus erythematosis (SLE)

- History of rheumatic fever

- Psoriasis

- Inflammatory bowel disease

- Osteoarthritis (OA)

- Known underlying rheumatological disease, joint problems known to be associated with
arthropathy.

- Patients with any pre-treatment baseline musculoskeletal exam abnormalities

- Known risk of experiencing seizures, a history of any convulsive disorders

- Requiring any concomitant therapeutic course of systemic antibacterial agent

- Participation in any industry-sponsored clinical drug development study within one
month prior to this study

- Known significant liver impairment (ALAT/ASAT and/or baseline bilirubin > 3 times
upper limit of normal)

- Known significant renal insufficiency (calculated creatinine clearance of < 30
ml/min/1.73 m²)

- Are pregnant or lactating, or are sexually active and using unreliable contraception.